Compare HCA Health Inc (HCA) vs Lemonade Inc (LMND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Lemonade Inc — how do they compare? HCA Health Inc trades at $443.69 (market cap $96.35B), while Lemonade Inc trades at $47.42 (market cap $3.63B). The key difference: HCA Health Inc is far larger — about 26.5× Lemonade Inc's market cap, and HCA Health Inc pays a 0.7% dividend while Lemonade Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Lemonade Inc for 27 Days on average.
| HCA | LMND | |
|---|---|---|
Market Cap | $96.35B | $3.63B |
Volume | 1,079,453 | 1,544,794 |
Sector | Health | Financials |
52-Week High | $545.13 | $96.57 |
52-Week Low | $361.32 | $43.91 |
Typical Hold Time | 76 Days | 27 Days |
Enterprise Value | $146.88B | $3.49B |
Dividend Yield | 0.7% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $439.17, up 1.61% on the day, with a bullish technical signal and strong fundamentals. The stock shows consistent revenue growth, reaching $75.6B in 2025, and has beaten EPS estimates for three consecutive quarters. Analyst consensus is bullish with a $461.12 price target, supported by solid cash flow from operations of $12.64B and a net income margin of 8.77%.
The outlook remains positive given earnings momentum and operational efficiency, but risks include ongoing legal investigations and high debt levels. Upside potential exists if the company maintains its earnings beat streak and manages payer-mix challenges effectively.
Lemonade (LMND) trades at $46.83, up 1.14% with a bearish technical outlook despite recent earnings beats. The company shows strong revenue growth from $257M in 2022 to $738M in 2025, though remains unprofitable with a -22.43% net margin. Analyst sentiment is evenly split between buy/hold/sell with a $67 consensus target, while institutional activity shows mixed positioning. Recent expansion into Alaska and Kentucky renters insurance and pet insurance markets supports growth trajectory.
Lemonade's path to profitability remains the key investment thesis, targeting EBITDA positivity by late 2026. The stock offers growth potential through AI-driven efficiency and market expansion but carries significant execution risk amid persistent losses. Current valuation at 3.63x sales appears reasonable for the growth profile, though technical weakness near support at $45 requires monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Lemonade Inc
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →
